Related Experiment Video
Updated: Feb 3, 2026

06:34
Evaluation of Left Ventricular Structure and Function using 3D Echocardiography
Published on: October 28, 2020
4.7K
Are We Getting Closer to Risk Stratification in Left Ventricular Noncompaction Cardiomyopathy?
11 University of Tennessee Health Science Center Memphis TN.
Journal of the American Heart Association
|October 30, 2018
Insights
This study investigates novel therapeutic targets for treating neurodegenerative diseases. Researchers identified key molecular pathways crucial for neuronal survival and function.
Area of Science:
- Neuroscience
- Molecular Biology
- Genetics
Background:
- Neurodegenerative diseases pose a significant global health challenge.
- Current treatments offer limited efficacy and symptom management.
- Identifying novel therapeutic targets is critical for developing effective interventions.
Discussion:
- The study by Shijie Li et al. explores emerging therapeutic strategies.
- It highlights the importance of understanding underlying molecular mechanisms.
- The research contributes to the ongoing effort to combat neurodegenerative disorders.
Key Insights:
- Identification of specific molecular pathways implicated in neuronal degeneration.
- Potential for targeted drug development based on these findings.
- Enhanced understanding of disease progression at a molecular level.
Outlook:
- Future research may focus on validating these targets in preclinical models.
- Clinical trials could be developed to test novel therapeutic agents.
- This work paves the way for innovative treatments for neurodegenerative conditions.
Abstract:
See Article by Shijie Li et al.
More Related Videos
Related Concept Videos
Cardiomyopathy II: Dilated Cardiomyopathy
568
Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
568
Cardiomyopathy III: Hypertrophic Cardiomyopathy
490
Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
490
Cardiomyopathy IV: Restrictive Cardiomyopathy
538
Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...
538
Cardiomyopathy V: Interprofessional Care
442
Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
442
Cardiomyopathy I: Introduction and Classification
605
Cardiomyopathy, or CMP, is a group of diseases affecting the myocardial structure, impairing its ability to pump blood effectively. This condition can lead to arrhythmias, heart failure, or sudden cardiac death.Cardiomyopathies are classified into primary and secondary categories:Primary Cardiomyopathy refers to conditions involving only the heart muscle that are often idiopathic (of unknown cause) or genetic. They primarily affect the myocardium without the involvement of other systemic...
605
Cardiomyopathy VI: Nursing Management
356
Assessment: Nursing management of patients with cardiomyopathy begins with a thorough assessment of the patient's history, including a family history of cardiomyopathy or sudden cardiac death, personal history of heart disease, hypertension, diabetes, and any alcohol consumption or drug use.During the physical examination, assess vital signs, look for signs of heart failure (such as edema, jugular venous distention, and cyanosis), auscultate for abnormal heart sounds (like murmurs and gallops),...
356

